US speciality ingredient firm Inolex has made three appointments to its leadership team.
Michael Dall has been appointed chief financial officer, Ron Lopez has been promoted to vice president of operations, while nationally recognized attorney Suzanne S. Mayes has been added to the Inolex board of directors.
In this new role, Dall (top) will provide pivotal leadership to the company’s overall financial strategy and its strong position for global development.
Dall, who served in executive roles at channel disrupting brands Wawa, Walgreens, Aramark, and BrightView, will take on broader responsibility for managing the financial health of the company as it delivers its portfolio of sustainable ingredients to new and extended markets.
Lopez (middle) has been promoted after being at the helm of the company’s flagship manufacturing facility in Charlotte, USA since 2021.
He has led the team responsible for ensuring continuous production and global fulfillment of Inolex ingredients to customers despite recent supply chain and global challenges.
Mayes (bottom), who regularly provides counsel to large scale municipal infrastructure improvements and economic development initiatives in the Mid-Atlantic region, has been tasked with challenging the Philadelphia firm to “think differently”.
“Suzanne's broad command of business and finance and her ability to facilitate change are unparalleled. We are thrilled to have her join the Board as we build the future of the company,” said Inolex CEO David Plimpton.
“We remain a fiercely independent company, which means we have great flexibility to make bold decisions on our path to advance sustainable ingredients,” he added.